Matches in Wikidata for { <http://www.wikidata.org/entity/Q70682302> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q70682302 description "artículu científicu espublizáu n'abril de 1981" @default.
- Q70682302 description "im April 1981 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70682302 description "scientific article published on 01 April 1981" @default.
- Q70682302 description "wetenschappelijk artikel" @default.
- Q70682302 description "наукова стаття, опублікована у квітні 1981" @default.
- Q70682302 name "Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers" @default.
- Q70682302 name "Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers" @default.
- Q70682302 type Item @default.
- Q70682302 label "Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers" @default.
- Q70682302 label "Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers" @default.
- Q70682302 prefLabel "Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers" @default.
- Q70682302 prefLabel "Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers" @default.
- Q70682302 P1433 Q70682302-FE152C99-440A-4748-9395-A58275B2E3A3 @default.
- Q70682302 P1476 Q70682302-E9A52463-6299-4525-84E2-79207CB8056C @default.
- Q70682302 P2093 Q70682302-04052D48-129D-4BE5-B8A4-E171481A4B84 @default.
- Q70682302 P2093 Q70682302-34E7F569-41E7-47D0-BD78-6197AA78DC65 @default.
- Q70682302 P2093 Q70682302-93F2B9CA-6046-47A9-8B4A-AAEC57E2DF90 @default.
- Q70682302 P2093 Q70682302-C121A896-CE1D-479A-B533-236DCF41B52C @default.
- Q70682302 P2093 Q70682302-DFFBF4ED-AF3C-4195-A113-EA3CF0BBC003 @default.
- Q70682302 P304 Q70682302-26FE5D24-FAE8-4826-ACB3-CA0E84170B6E @default.
- Q70682302 P31 Q70682302-1E4D2CBD-0912-4E7E-A32D-A54C23517E7B @default.
- Q70682302 P407 Q70682302-7054E4A2-D1D6-4AF6-A574-BE6A1C6CE03C @default.
- Q70682302 P433 Q70682302-33E89818-93DB-48CB-A0C7-3B26738CC4D8 @default.
- Q70682302 P478 Q70682302-306B3711-458B-48DB-BC94-C3516449C96A @default.
- Q70682302 P577 Q70682302-93F58A48-5F9F-4CDC-B1DB-7F5E47561C80 @default.
- Q70682302 P698 Q70682302-117256E5-9E9B-4F7C-9282-ED267DF40C3F @default.
- Q70682302 P921 Q70682302-1A22AD05-C479-4DF9-B815-37DDAC47C684 @default.
- Q70682302 P921 Q70682302-5DEF1ED7-43D2-439B-B8E2-09404D12F4F9 @default.
- Q70682302 P698 7202937 @default.
- Q70682302 P1433 Q4039279 @default.
- Q70682302 P1476 "Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers" @default.
- Q70682302 P2093 "Casian C" @default.
- Q70682302 P2093 "Go VL" @default.
- Q70682302 P2093 "Rojas S" @default.
- Q70682302 P2093 "Sierra JG" @default.
- Q70682302 P2093 "Uribe M" @default.
- Q70682302 P304 "661-665" @default.
- Q70682302 P31 Q13442814 @default.
- Q70682302 P407 Q1860 @default.
- Q70682302 P433 "4" @default.
- Q70682302 P478 "80" @default.
- Q70682302 P577 "1981-04-01T00:00:00Z" @default.
- Q70682302 P698 "7202937" @default.
- Q70682302 P921 Q461809 @default.
- Q70682302 P921 Q929737 @default.